✦ LIBER ✦

Accelerated and blastic phases of chronic myelogenous leukemia

✍ Scribed by Giles, Francis J; Cortes, Jorge E; Kantarjian, Hagop M; O'Brien, Susan M

Book ID: 121950827
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 270 KB
Volume: 18
Category: Article
ISSN: 0889-8588
DOI: 10.1016/j.hoc.2004.03.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of decitabine therapy in the acc

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia

✍ Kantarjian, H M; O’Brien, S M; Keating, M; Beran, M; Estey, E; Giralt, S; Kornbl 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 197 KB

Blastic phase of chronic myelogenous leu

Blastic phase of chronic myelogenous leukemia

✍ Merat Karbasian Esfahani; Evelyn L. Morris; Janice P. Dutcher; Peter H. Wiernik 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 478 KB

Accelerated and blastic phase of chronic

Accelerated and blastic phase of chronic myeloid leukemia

✍ Janice P. Dutcher; Peter H. Wiernik 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 350 KB

Chronic myelogenous leukemia presenting

Chronic myelogenous leukemia presenting in blastic crisis

✍ Richard S. Bornstein; Mark Nesbit; B. J. Kennedy 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

Chronic myelogenous leukemia (CML) is the only h a m a n neoplastic disease associated with a specific cytogenetic abnormality, the Philadelphia (Phl) chromosome. This marker chromosome is found in the majority of patients with CML and has only occasionally been reported in other hematologic conditi

Diverse mechanisms of mTOR activation in

Diverse mechanisms of mTOR activation in chronic and blastic phase of chronic myelogenous leukemia

✍ Stoklosa, Tomasz; Glodkowska-Mrowka, Eliza; Hoser, Grazyna; Kielak, Magdalena; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 726 KB

Sudden onset of the blastic phase of chr

Sudden onset of the blastic phase of chronic myelogenous leukemia : Patterns and implications

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Deborah Thomas; St 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract ## BACKGROUND Therapeutic options in Philadelphia chromosome‐positive chronic myelogenous leukemia (Ph‐positive CML) in chronic phase include allogeneic stem cell transplantation (SCT) and treatments other than allogeneic SCT. The choice of therapy often depends on the mortality risk o